OraSure Technologies Inc
OSUR
View Detailed Chart
2.933USD
-0.137-4.47%
Market hours （ET）Quotes delayed by 15 min
141.02MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-4.47%
5 Days
-0.59%
1 Month
-6.90%
6 Months
-7.78%
Year to Date
+21.19%
1 Year
-14.50%
View Detailed Chart
TradingKey Stock Score of OraSure Technologies Inc
Currency: USD Updated: 2026-03-27Key Insights
OraSure Technologies Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 49 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OraSure Technologies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
OraSure Technologies Inc Highlights
StrengthsRisks
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
Fairly Valued
The company’s latest PE is -3.21, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 65.20M shares, decreasing 20.60% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 137.17K shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
4.000
Target Price
+30.29%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
OraSure Technologies Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OraSure Technologies Inc Info
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.
Ticker SymbolOSUR
CompanyOraSure Technologies Inc
CEOEglinton Manner (Carrie)
Websitehttps://www.orasure.com/
Related Instruments
+0.83%
-0.54%
-1.17%
-3.70%
-2.30%
+1.02%
-0.34%
-2.92%
-1.81%
-1.98%
-9.30%
-0.50%
-4.72%
-2.36%
+0.76%
-3.25%
-1.31%
-1.05%
-1.01%
-2.13%Popular Symbols
246.419
-2.381 (-0.96%)
165.440
-2.080 (-1.24%)
66626.200
+42.150 (+0.06%)
252.125
-21.225 (-7.76%)
2028.910
+28.910 (+1.45%)
355.640
-6.190 (-1.71%)
4500.360
+7.840 (+0.18%)
102.452
+1.843 (+1.83%)
1.146
-0.004 (-0.39%)
159.623
-0.629 (-0.39%)
